Remove Clinical Development Remove Cosmetics Remove Drug Delivery Remove Marketing
article thumbnail

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Continue to Adorn the Space

Delveinsight

The condition is not life-threatening, however, is often wrongly presumed as purely a cosmetic problem leading to ignorance and delay in the treatment. The Onychomycosis treatment market offers several options, including oral antifungals, topical antifungals, and devices. Penlac (Valeant Pharmaceuticals, Inc.),

article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). For additional information, please visit www.crescitatherapeutics.com.